Db Fitzpatrick & Co, Inc Thermo Fisher Scientific Inc. Transaction History

Db Fitzpatrick & Co, Inc

$107 Million
Q2 2024

A detailed history of Db Fitzpatrick & Co, Inc transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Db Fitzpatrick & Co, Inc holds 3,398 shares of TMO stock, worth $2.03 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

3,398

Previous 3,419 0.61%

Holding current value

$2.03 Million

Previous $1.99 Million 5.44%

% of portfolio

1.75%

Previous 1.83%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$541.52 - $599.02 $11,371 - $12,579	-21 Reduced 0.61%	3,398 $1.88 Million
Q1 2024 Apr 19, 2024	SELL	$528.82 - $599.43 $30,671 - $34,766	-58 Reduced 1.67%	3,419 $1.99 Million
Q4 2023 Jan 23, 2024	BUY	$431.41 - $532.94 $225,196 - $278,194	522 Added 17.66%	3,477 $1.85 Million
Q3 2023 Nov 01, 2023	BUY	$498.29 - $574.41 $39,364 - $45,378	79 Added 2.75%	2,955 $1.5 Million
Q2 2023 Aug 09, 2023	SELL	$508.46 - $591.13 $67,116 - $78,029	-132 Reduced 4.39%	2,876 $1.5 Million
Q1 2023 Apr 24, 2023	BUY	$535.0 - $604.82 $28,890 - $32,660	54 Added 1.83%	3,008 $1.73 Million
Q4 2022 Jan 24, 2023	SELL	$484.71 - $571.37 $38,776 - $45,709	-80 Reduced 2.64%	2,954 $0
Q3 2022 Oct 20, 2022	SELL	$507.19 - $604.49 $204,397 - $243,609	-403 Reduced 11.73%	3,034 $1.54 Million
Q2 2022 Jul 28, 2022	BUY	$500.9 - $612.21 $4,508 - $5,509	9 Added 0.26%	3,437 $1.87 Million
Q1 2022 Apr 22, 2022	BUY	$524.0 - $644.92 $33,012 - $40,629	63 Added 1.87%	3,428 $2.03 Million
Q4 2021 Feb 03, 2022	BUY	$569.0 - $667.24 $1.91 Million - $2.25 Million	3,365 New	3,365 $2.25 Million

Others Institutions Holding TMO

# of Institutions

2,779

Shares Held

340M

Call Options Held

1.42M

Put Options Held

2.15M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $235B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Db Fitzpatrick & Co, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Db Fitzpatrick & Co, Inc with notifications on news.

Account

Db Fitzpatrick & Co, Inc Thermo Fisher Scientific Inc. Transaction History